Erythemas

Also known as: Erythema / Erythematous condition, unspecified / Skin red / Skin erythema / Erythema of skin (disorder) / Erythema (finding) / Erythema (morphologic abnormality) / Erythema NOS / Unspecified erythematous condition

Drug	Drug Name	Drug Description
DB13501	Bendazac	A non-steroidal anti-inflammatory drug (NSAID) available as an eye drop for the treatment of cataracts and as a topical cream for the treatment of dermatitis, eczema, hives, skin ulcers and other inflammatory skin conditions.
DB02703	Fusidic acid	A topical antibacterial agent used to prevent and treat mild to moderate skin infections caused by susceptible bacteria.

Drug	Drug Name	Target	Type
DB13501	Bendazac	Free radicals	target
DB13501	Bendazac	Prostaglandin G/H synthase 1	target
DB13501	Bendazac	Prostaglandin G/H synthase 2	target
DB02703	Fusidic acid	Chloramphenicol acetyltransferase 3	target
DB02703	Fusidic acid	Chloramphenicol acetyltransferase	target
DB02703	Fusidic acid	Bile salt export pump	transporter
DB02703	Fusidic acid	Canalicular multispecific organic anion transporter 1	transporter
DB02703	Fusidic acid	Elongation factor G	target
DB02703	Fusidic acid	Cytochrome P450 2D6	enzyme
DB02703	Fusidic acid	Cytochrome P450 3A4	enzyme
DB02703	Fusidic acid	UDP-glucuronosyltransferase 1-1	enzyme
DB02703	Fusidic acid	ATP-binding cassette sub-family G member 2	transporter
DB02703	Fusidic acid	Solute carrier organic anion transporter family member 1B1	transporter

Drug	Drug Name	Phase	Status	Count
DB00741	Hydrocortisone	1	Completed	1
DB00958	Carboplatin	2	Active Not Recruiting	1
DB09357	Dexpanthenol	2	Completed	1
DB01229	Paclitaxel	2	Active Not Recruiting	1
DB01269	Panitumumab	2	Active Not Recruiting	1
DB09037	Pembrolizumab	2	Active Not Recruiting	1
DB00548	Azelaic acid	3	Completed	1
DB00484	Brimonidine	3	Completed	2
DB00935	Oxymetazoline	3	Completed	3
DB09357	Dexpanthenol	4	Completed	1
DB00799	Tazarotene	4	Completed	1